Huma to attend 41st Annual J.P. Morgan Healthcare Conference

First published:
January 3, 2023
mins read

NEW YORK, Jan 3, 2023 Huma Therapeutics Limited (“Huma”), the global digital health company, today announced that its Chief Executive Officer and Founder, Dan Vahdat, and Chief Financial and Strategy Officer, Ingeborg Oie, will be attending the main conference at the upcoming 41st Annual J.P. Morgan Healthcare Conference in San Francisco, US, from 9-12 January 2023. 

Dan and Inge are excited to return in person to the main conference after the virtual meetings of the pandemic, and are looking forward to reconnecting with existing, and meeting new, partners face-to-face to discuss how Huma’s digital technology advances proactive, predictive care for all patients and accelerates research and therapies. 

To connect with Dan and Ingeborg at JPM, please reach out to Connie at 

For journalists who would like to talk with Dan and Inge, please reach out to Sian at or Karen at